Blue Horseshoe Stocks: ITEK Recap, Options Ideas & More

Inotek Pharmaceutical Corp. ITEK

Our report for yesterday brought a couple of nice opportunities, with ITEK standing out as the most impressive. We caught this play on our routine morning scan, after noticing some abnormally elevated premarket activity. The company had released some information regarding its glaucoma treatment exiting Phase II studies and laying a strategic path for Phase III, and needless to say, it was very well-received.

This wasn’t a blink-and-you’ll-miss-it sort of move either, with just a small move up to start the session, ITEK traded sideways for most of the morning. Just prior to lunchtime is when we started to see the beginnings of an epic intraday run, especially for a stock in this price range.

From a low of  7.66, the stock exploded to reach a daily (and new annual) high of 16.75, standing as a single-session surge of 119%  The overall move as of this morning’s premarket high of 18.20 registers as an overnight increase of 138%  Cheers go out to any of our readers who caught our alert!

Inotek Pharmaceuticals Announces Positive End-of-Phase 2 Meeting with FDA and Phase 3 Development Strategy for Trabodenoson, a Novel Treatment for Glaucoma (Thu, Jul 23)


WindStream Technologies, Inc. WSTI

It was Tuesday’s Letter to Shareholders that caught our eye in the premarket news feed, causing us to raise a flag on WSTI that morning.

We’ve covered it every day since, and have been rewarded with incremental gains throughout, with the stock recording higher highs and higher lows each session. Yesterday, we witnessed an intraday run from .0172-.0244, which yielded the chance at gains of up to 42% on the day.

From our observed low on Tuesday (the 52-week low of .0085) we’ve now seen an overall jump in WSTI amounting to 187% in just three session’s time. Refer to the annotated chart below to evaluate WSTI’s chances of making further advances from this juncture.


Friday Options Ideas

If you recall last Friday, we came up huge with an alert on Weekly GOOG Calls.  We mentioned how time-decay at this point in the week begins to evaporate premiums in contracts with a weekly expiration, and generates a high-octane volatile environment where big gains are often there for the taking for those who can assume a higher-than-average risk.  A 694% intraday run from one of the sets of contracts we highlighted in that report was there to prove our point.

___

We’re going to venture a similar set of ideas this morning for Weekly AMZN Calls in the $575-595 range. The stock is gapping up hard this morning to the tune of 20%, thus we will have our eyes peeled for a classic dip-and-rip scenario.

___

We’re also going to put a marker flag on Weekly FB Calls from $96-50-97.50. The stock is rebounding off of a pullback over the past couple of days, after performing extremely well for the majority of this month.


Extended Watchlist:
AMDA, ACRX, CALA, ICLD, CRGP(news), HERO(52-wk lows)

Blue Horseshoe Stocks: PBMD Recap, ASTI News & More

Prima BioMed, Ltd. PBMD

PBMD stood out among yesterday’s fresh news plays with a solid performance on the day. It was helped along by the announcement that the European Medicines Agency had given positive Scientific Advice with regard to the development path for its metastatic breast cancer treatment.

We observed as the stock traded in a daily range from 1.42 to 1.78, representing a respectable 25% intraday swing, and it did so on the strength of nearly 3.5X its 3-month average volume.

Looking at some of the still-bullish features PBMD chart, we’re going to stay open to the possibility of seeing further upswings in the near future:


American Green, Inc. ERBB

We highlighted ERBB on Friday as a potential bottom-watch candidate, and the stock has responded with a nice move so far this week. It was trading at a low of .0039 to start things off on Monday, and yesterday we watched as it reached a .0049 high; a two-day swing of 26%

The company just completed an important step in their current business plan which was reported in a PR yesterday (link below). It was in reference to the partnership ERBB has formed to construct a legal marijuana grow operation in Colorado, which will purportedly focus solely upon the propagation of “CBD-rich cannabis strains”. It’s a story we’ll continue to follow as more details become available.


Ascent Solar Technologies, Inc. ASTI

We’re also still on alert with regard to an inclusion in Monday’s premarket report; ASTI has been making its way toward a bottom for the past few months. Yesterday we observed a low .451 toward the end of the session, and it appears that will be marked down as the the rebound point as the stock is gapping up heavily in early trading today with the help of a very positive PR.

As of this morning’s premarket high of .80 we’ve already seen a 77% swing in less than 24 hours. We’ll keep a close watch on ASTI today as this morning’s news of its 233% quarter-over-quarter revenue increase filters down and reaches more sets of eyes.


Extended Watchlist:
BTU, IPDN, UWTI, OCLS, GBSN, AMDA, CNXS(>Interesting PR)

Blue Horseshoe Stocks: Options Update & Much More

Amedica Corp. AMDA

After providing us with the chance for intraweek gains of 61% last week, as we were mentioning in yesterday’s morning report, AMDA turned in another healthy performance for the day.

From a morning low of .58, the stock pressed to a new high of .70; a 21% intraday move, and this morning the stock is gapping up once again. As of this morning’s premarket high, the total range we’ve now observed in AMDA in just a week’s time stands at 102% from last Tuesday’s low of .3851.

Yesterday’s solid showing also marked the fifth consecutive trading day that AMDA managed to register higher lows and higher highs. We’ll continue to track its activity as the week progresses. A dip-and-rip off of this morning’s new high is a distinct possibility.


Under Armour, Inc. UA – Options Update

UA was a point of focus for us on Friday morning, at which time we submitted a medium-term options idea for the stock, namely the 07/31 $84 Calls. We wanted to provide an update on the subsequent performance of those contracts, which managed a notable increase between Friday and yesterday.

From a low of 2.76, the July $84’s have traded as high as 3.53 thus far. That hashes out to total possible gains of 28% over just a couple of trading sessions. With plenty of time left until expiration, we’ll be sure to keep a slot reserved for those contracts from this point forward.


TapImmune, Inc. TPIV

We’ve been tracking TPIV for nearly two weeks now. We tagged it for the first time on June 10th, and we slipped a reminder into Friday’s report as well.

We certainly hope those alerts caught someone’s attention, because TPIV has certainly caught ours; yesterday’s high of 1.23 represented a 28% jump from the low following Friday’s alert (.962) and an overall increase of 71% from the low following our initial alert (.72).


Sipp Industries, Inc. SIPC

SIPC is catching our attention this morning after announcing the addition of “Hemp co-packing, storage, distribution, and private label solutions to product offering.” in an early PR. It caused us to take notice of the chart, which is currently boasting an attractive setup with regard to its potential as a bottom-play. We’re going to keep a close eye on SIPC as we head into mid-week.


Extended Watchlist:
PHMD, BIND, NSPR, TBIO, BBRY